Search - tctmd.com

Displaying 61 - 80 of 99

Sort: Relevancy | Date

Presentation TCT 2020

TCT 484: Inclusion of Very Small Cerebral Lesions in Quantitative Embolic Protection Study Endpoints May Obscure Clinical Relevance

Presenter: Michael Dwyer

October 14, 2020

Presentation TCT 2020

TCT 471: A Novel Computed Tomographic Angiography Tortuosity Index to Predict Successful Sentinel Cerebral Embolic Protection Delivery for Transcatheter Aortic Valve Replacement

Presenter: Denny Wang

October 14, 2020

Innovation Gone Wild - Next-Generation TRIGUARD Cerebral Embolic Protection During TAVR: Technology Review and Status of Ongoing Clinical Trials

Presentation TCT 2019

Next-Generation TRIGUARD Cerebral Embolic Protection During TAVR: Technology Review and Status of Ongoing Clinical Trials

Presenter: Tamim Nazif

September 27, 2019

Aortic Valve Intervention and Ancillary Solutions I: Featured Technological Trends - Full Arch Cerebral Embolic Protection of the Brain (Point-Guard™) During Cardiovascular Procedures

Presentation TCT 2019

Full Arch Cerebral Embolic Protection of the Brain (Point-Guard™) During Cardiovascular Procedures

Presenter: Axel Linke

September 25, 2019

Presentation TCT 2019

TCT 23: Heterogeneity of Debris Captured by Cerebral Embolic Protection Filters During Transcatheter Aortic Valve Replacement With Different Transcatheter Heart Valves

Presenter: Nicolas van Mieghem

September 25, 2019

Presentation TCT 2018

Cerebral Embolic Protection: Regulatory Perspectives

Presenter: Jeffrey J. Popma, Changfu Wu, Kenneth J. Cavanaugh Jr

September 23, 2018

Presentation TCT 2018

Cerebral Embolic Protection for TAVR Procedures: A Critical Appraisal

Presenter: Jeffrey J. Popma, Changfu Wu, Samir R. Kapadia

September 23, 2018

Presentation TCT 2018

Case #2: A Case of Embolic Protection in Difficult Cerebral Anatomy

Presenter: Philippe Genereux, Josep Rodés-Cabau, Suzanne V. Arnold, Wayne B. Batchelor, Pablo Lamelas, Tullio Palmerini, Shigeru Saito, Tobias Tichelbäcker

September 23, 2018

Presentation TCT 2018

NO The Data are Inconclusive and the Costs are Prohibitive!

Presenter: John K. Forrest

September 22, 2018

Presentation TCT 2018

YES Review of ALL the Data and Common Sense Tell the Story!

Presenter: Susheel K. Kodali

September 22, 2018

Presentation TCT 2018

Keystone TRIGUARD Cerebral Embolic Protection During TAVR: New Generation Devices and the Status of Ongoing Clinical Trials

Presenter: Alexandra J. Lansky, Axel Linke, Tamim Nazif

September 22, 2018

Presentation TCT 2018

Cedars-Sinai Medical Center (USA

Presenter: Tarun Chakravarty

September 22, 2018

Presentation TCT 2018

Erasmus University (The Netherlands)

Presenter: Herbert Kroon

September 22, 2018

Presentation TCT 2018

Ulm University (Germany)

Presenter: Jochen Wöhrle

September 22, 2018

Presentation TCT 2018

TCT-4: Reduction of Stroke With Use of the Double-Filter Cerebral Embolic Protection Device in Patients Undergoing Transfemoral Aortic Valve Replacement With Self-Expandable, Mechanically Implantable And Balloon-Expandable Aortic Valves

Presenter: Steven R. Bailey, Patrick W. Serruys, Julia Seeger

September 22, 2018

Presentation TCT 2018

A Stroke after TAVR Primer: Time Course, Changing Incidence, Ascertainment Challenges, and Comparison vs. Surgery

Presenter: Alexandra J. Lansky, Axel Linke, Samir R. Kapadia

September 22, 2018

Presentation TCT 2018

TCT-98: Early Clinical Impact of Cerebral Embolic Protection With Transcatheter Aortic Valve Replacement, a Multicenter Study in the Netherlands

Presenter: Alain G. Cribier, Helene Eltchaninoff, Herbert Kroon

September 21, 2018

News Conference News TCT 2017

Experts Debate: Should Cerebral Protection Be Used for All TAVRs?

Todd Neale

November 09, 2017

Presentation TCT 2017

TCT 36: Cerebral Embolic Protection During Transfemoral Aortic Valve Replacement Reduces Death and Stroke Compared to Unprotected Procedure in All Subgroups

Presenter: Reginald I. Low, Michael J. Rinaldi, Julia Seeger

October 31, 2017

Presentation TCT 2017

Germany Presents: Case Introduction - TAVR in a Low-Risk Patient With Cerebral Embolic Protection

Presenter: Dariusz Dudek, Martin Hudec, Julia Seeger

October 30, 2017

Advertisement

TCT 484: Inclusion of Very Small Cerebral Lesions in Quantitative Embolic Protection Study Endpoints May Obscure Clinical Relevance

TCT 471: A Novel Computed Tomographic Angiography Tortuosity Index to Predict Successful Sentinel Cerebral Embolic Protection Delivery for Transcatheter Aortic Valve Replacement

Next-Generation TRIGUARD Cerebral Embolic Protection During TAVR: Technology Review and Status of Ongoing Clinical Trials

Full Arch Cerebral Embolic Protection of the Brain (Point-Guard™) During Cardiovascular Procedures

TCT 23: Heterogeneity of Debris Captured by Cerebral Embolic Protection Filters During Transcatheter Aortic Valve Replacement With Different Transcatheter Heart Valves

Cerebral Embolic Protection: Regulatory Perspectives

Cerebral Embolic Protection for TAVR Procedures: A Critical Appraisal

Case #2: A Case of Embolic Protection in Difficult Cerebral Anatomy

NO The Data are Inconclusive and the Costs are Prohibitive!

YES Review of ALL the Data and Common Sense Tell the Story!

Keystone TRIGUARD Cerebral Embolic Protection During TAVR: New Generation Devices and the Status of Ongoing Clinical Trials

Cedars-Sinai Medical Center (USA

Erasmus University (The Netherlands)

Ulm University (Germany)

TCT-4: Reduction of Stroke With Use of the Double-Filter Cerebral Embolic Protection Device in Patients Undergoing Transfemoral Aortic Valve Replacement With Self-Expandable, Mechanically Implantable And Balloon-Expandable Aortic Valves

A Stroke after TAVR Primer: Time Course, Changing Incidence, Ascertainment Challenges, and Comparison vs. Surgery

TCT-98: Early Clinical Impact of Cerebral Embolic Protection With Transcatheter Aortic Valve Replacement, a Multicenter Study in the Netherlands

Experts Debate: Should Cerebral Protection Be Used for All TAVRs?

TCT 36: Cerebral Embolic Protection During Transfemoral Aortic Valve Replacement Reduces Death and Stroke Compared to Unprotected Procedure in All Subgroups

Germany Presents: Case Introduction - TAVR in a Low-Risk Patient With Cerebral Embolic Protection

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content